Everolimus and Reduced-Exposure Cyclosporine in de novo Renal-Transplant Recipients: A Three-Year Phase II, Randomized, Multicenter, Open-Label Study

Transplantation Journal ◽

10.1097/01.tp.0000140486.97461.49 ◽

2004 ◽

Vol 78 (9) ◽

pp. 1332-1340 ◽

Author(s):

Bj??rn Nashan ◽

John Curtis ◽

Claudio Ponticelli ◽

Georges Mourad ◽

Jonathan Jaffe ◽

...

Keyword(s):

Renal Transplant ◽

Phase Ii ◽

De Novo ◽

Renal Transplant Recipients ◽

Transplant Recipients ◽

Open Label Study ◽

Download Full-text

AN OPEN-LABEL STUDY OF 3 DAYS OF THYMOGLOBULIN FOR INDUCTION IN ADULT RENAL TRANSPLANT RECIPIENTS

Transplantation Journal ◽

10.1097/00007890-199904150-00590 ◽

1999 ◽

Vol 67 (7) ◽

pp. S147 ◽

Author(s):

D C Brennan ◽

K Flavin ◽

M Mahon ◽

S Burgess ◽

T Howard ◽

...

Keyword(s):

Renal Transplant ◽

Renal Transplant Recipients ◽

Transplant Recipients ◽

Open Label Study ◽

Download Full-text

A MULTICENTER, OPEN LABEL PILOT STUDY OF EARLY (5 DAY) CORTICOSTEROID CESSATION IN DE NOVO RENAL TRANSPLANT RECIPIENTS UNDER SIMULECT, TACROLIMUS, AND SIROLIMUS THERAPY: ONE YEAR RESULTS

Transplantation Journal ◽

10.1097/00007890-200407271-00443 ◽

2004 ◽

Vol 78 ◽

pp. 169 ◽

Author(s):

E S Woodle ◽

F Vincenti ◽

M Lorber ◽

A Gritsch ◽

D Hricik ◽

...

Keyword(s):

Pilot Study ◽

Renal Transplant ◽

De Novo ◽

Renal Transplant Recipients ◽

Transplant Recipients ◽

Download Full-text

A multicenter, open-label, pharmacokinetic/pharmacodynamic safety, and tolerability study of basiliximab (Simulect) in pediatric de novo renal transplant recipients

Transplantation Journal ◽

10.1097/00007890-200210150-00010 ◽

2002 ◽

Vol 74 (7) ◽

pp. 961-966 ◽

Author(s):

Gisela Offner ◽

Michel Broyer ◽

Patrick Niaudet ◽

Chantal Loirat ◽

Mark Mentser ◽

...

Keyword(s):

Renal Transplant ◽

De Novo ◽

Renal Transplant Recipients ◽

Transplant Recipients ◽

Download Full-text

A 12-month, multicenter, randomized, adaptive design, open-label study to evaluate the benefit of C2 hour monitoring of neoral on safety and efficacy outcomes in de novo cardiac transplant recipients receiving basiliximab induction

The Journal of Heart and Lung Transplantation ◽

10.1016/j.healun.2003.11.196 ◽

2004 ◽

Vol 23 (2) ◽

pp. S107 ◽

Author(s):

M Cantarovich ◽

H Ross ◽

J Arizon ◽

J Orus ◽

L Straatman ◽

...

Keyword(s):

Adaptive Design ◽

De Novo ◽

Cardiac Transplant ◽

Transplant Recipients ◽

Open Label Study ◽

Label Study ◽

Safety And Efficacy

Download Full-text

A 3-month, Multicenter, Randomized, Open-label Study to Evaluate the Impact on Wound Healing of the Early (vs Delayed) Introduction of Everolimus in De Novo Kidney Transplant Recipients, With a Follow-up Evaluation at 12 Months After Transplant (NEVERWOUND Study)

Transplantation Journal ◽

10.1097/tp.0000000000002851 ◽

2020 ◽

Vol 104 (2) ◽

pp. 374-386 ◽

Author(s):

Tommaso Maria Manzia ◽

Mario Carmellini ◽

Paola Todeschini ◽

Antonio Secchi ◽

Silvio Sandrini ◽

...

Keyword(s):

Wound Healing ◽

Kidney Transplant ◽

De Novo ◽

Transplant Recipients ◽

Kidney Transplant Recipients ◽

Open Label Study ◽

Label Study ◽

Download Full-text

Early Conversion of Calcineurin Inhibitor to Everolimus in De Novo Paediatric Renal Transplant Recipients and Its Impact on Efficacy and Renal Function; Design of An Open-Label, Randomised, Multi-Centre Study

Transplantation Journal ◽

10.1097/00007890-201211271-02397 ◽

2012 ◽

Vol 94 (10S) ◽

pp. 1208 ◽

Author(s):

B. Tönshoff ◽

L. Pape ◽

R. Ettenger ◽

L. Dello Strologo ◽

P. Niaudet ◽

...

Keyword(s):

Renal Function ◽

Renal Transplant ◽

Calcineurin Inhibitor ◽

De Novo ◽

Renal Transplant Recipients ◽

Transplant Recipients ◽

Multi Centre Study ◽

Centre Study ◽

Function Design

Download Full-text

AN OPEN-LABEL PILOT STUDY TO EVALUATE THE OPTIMAL NEORAL LEVELS WITH AUC0-4 MONITORING PLUS BASILIXIMAB IN DE NOVO RENAL TRANSPLANT RECIPIENTS.

Transplantation Journal ◽

10.1097/00007890-200407271-00710 ◽

2004 ◽

Vol 78 ◽

pp. 268

Author(s):

T Haba ◽

K Uchida ◽

Y Tominaga ◽

A Katayama ◽

S Matsuoka ◽

...

Keyword(s):

Pilot Study ◽

Renal Transplant ◽

De Novo ◽

Renal Transplant Recipients ◽

Transplant Recipients ◽

Download Full-text

A 12-month, multicenter, randomized, adaptive design, open-label study to evaluate the benefit of C2-hr monitoring of Neoral on safety and efficacy outcomes in de novo cardiac transplant recipients receiving basiliximab induction: 6-month outcomes

The Journal of Heart and Lung Transplantation ◽

10.1016/j.healun.2004.11.085 ◽

2005 ◽

Vol 24 (2) ◽

pp. S62 ◽

Author(s):

H. Ross ◽

M. Cantarovich ◽

J. Arizon ◽

J. Orus ◽

L. Straatman ◽

...

Keyword(s):

Adaptive Design ◽

De Novo ◽

Cardiac Transplant ◽

Transplant Recipients ◽

Open Label Study ◽

Label Study ◽

Safety And Efficacy

Download Full-text

Efficacy and Safety of Enteric-Coated Mycophenolate Sodium in De Novo Renal Transplant Recipients: Pooled Data From Three 12-Month Multicenter, Open-Label, Prospective Studies

Transplantation Proceedings ◽

10.1016/j.transproceed.2007.03.064 ◽

2007 ◽

Vol 39 (5) ◽

pp. 1386-1391 ◽

Author(s):

C. Legendre ◽

D. Cohen ◽

M. Zeier ◽

L. Rostaing ◽

K. Budde

Keyword(s):

Renal Transplant ◽

Prospective Studies ◽

De Novo ◽

Renal Transplant Recipients ◽

Efficacy And Safety ◽

Transplant Recipients ◽

Mycophenolate Sodium ◽

Pooled Data ◽

Download Full-text

A 12-MONTH, MULTICENTER, RANDOMIZED, ADAPTIVE DESIGN, OPEN-LABEL STUDY TO EVALUATE THE BENEFIT OF C2 HOUR MONITORING OF NEORAL ON SAFETY AND EFFICACY OUTCOMES IN DE NOVO CARDIAC TRANSPLANT RECIPIENTS RECEIVING BASILIXIMAB INDUCTION

Transplantation Journal ◽

10.1097/00007890-200407271-01123 ◽

2004 ◽

Vol 78 ◽

pp. 420

Author(s):

M Cantarovich ◽

H Ross ◽

J Arizon ◽

M A. Gomez ◽

L Straatman ◽

...

Keyword(s):

Adaptive Design ◽

De Novo ◽

Cardiac Transplant ◽

Transplant Recipients ◽

Open Label Study ◽

Label Study ◽

Safety And Efficacy

Download Full-text